News From The American Chemical Society, June 25, 2008 The tummy's taste for red wine with red meat What happens when red wine meets red meat? If the rendezvous happens in the stomach, scientists in Israel are reporting, wine's bounty of
healthful chemical compounds may thwart formation of harmful substances released during digestion of fat in the meat.
Source: www.medicalnewstoday.comLos Angeles Daily News Examines Connection Between High Number Of Minority Children In Foster Care System, Drug Tests Given To Minority Mothers Some
health care officials maintain that the high population of minority children in the foster care system can be attributed in part to hospitals and welfare agencies disproportionately administering drug tests to low-income, pregnant minority women who seek public
health care, the Los Angeles Daily News reports.
Source: www.medicalnewstoday.comNew EFPIA Code Of Practice On Relationships With Patient Organisations Effective In 31 Countries On 1 July 2008, a new Code of Practice comes into effect across Europe to ensure relationships between the pharmaceutical industry and patient organisations are transparent and ethical. The "Code of Practice on Relationships between the Pharmaceutical Industry and Patient Organisations", adopted in October 2007, applies to the 2,200 companies that the European Pharmaceutical Industry Association EFPIA represents directly and indirectly in 31 European countries.
Source: www.medicalnewstoday.comStillbirths, Infant Deaths Lead To Anxiety, Guilt Among Obstetricians Nearly one in 10 obstetricians in a new study has considered giving up obstetric practice because of the emotional toll of stillbirths and infant deaths. Three-quarters of the 804 obstetricians who responded to a survey by researchers at the University of Michigan
Health System reported that the experience took a large emotional toll on them personally.
Source: www.medicalnewstoday.comLa. Gov. Jindal Signs Ban On Funding For Research Involving Somatic Cell Nuclear Transfer Louisiana Gov. Bobby Jindal (R) recently signed into law a bill (HB 370) that prohibits the use of state or federal funds for research involving human somatic cell nuclear transfer, the
Source: www.medicalnewstoday.comPharmaceutical Companies Say New Approach By FDA Has Led To Decrease In Approvals Of New Medications An "intensifying focus on safety and a diminished tolerance for side effects" by FDA have "dramatically lowered" the chances that experimental medications will reach the market and have led to a recent decrease in approvals of new treatments, according to pharmaceutical companies, the Wall Street Journal reports.
Source: www.medicalnewstoday.comSenate GOP Continues To Block Bill To Reauthorize Global HIV/AIDS Bill Despite Bush's Support Several Senate Republicans on Friday blocked efforts to bring a bill (S 2731) to the Senate floor that would reauthorize funding for the President's Emergency Plan for AIDS Relief despite President Bush's support for the measures, CQ Today reports. Senate Majority Leader Harry Reid (D-Nev.
Source: www.medicalnewstoday.comClinical Data Secures EU Patent For MDR1 - A Key Multi-Drug Resistance Gene Clinical Data, Inc. (NASDAQ: CLDA), a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that the European Patent Office has granted Patent No. 1232260 to Bernried, Germany-based Epidauros Biotechnologie AG, a wholly-owned subsidiary of Clinical Data, relating to the use of a genetic variant, or biomarker, of the gene MDR1 (also known as ABCB1), which encodes P-glycoprotein (PGP).
Source: www.medicalnewstoday.com
# posted by Network @ 2:00 PM
